ICPMS
Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Language Čeština

    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma | LabRulez ICPMS

    USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-MS Solution

    Technical notes
    | 2021 | Agilent Technologies
    Software, HPLC, ICP/MS, Speciation analysis
    Instrumentation
    Software, HPLC, ICP/MS, Speciation analysis
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Enterprise Content Manager (ECM)

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

    Technical notes
    | 2022 | Agilent Technologies
    FTIR Spectroscopy
    Instrumentation
    FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Fast, Easy, and Reliable Measurements of Liquid Samples Using Transmission FTIR

    Applications
    | 2021 | Agilent Technologies
    FTIR Spectroscopy
    Instrumentation
    FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma

    Technical notes
    | 2016 | Agilent Technologies
    Software, UV–VIS spectrophotometry
    Instrumentation
    Software, UV–VIS spectrophotometry
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent SpectrAA CFR software

    Technical notes
    | 2020 | Agilent Technologies
    Software, AAS
    Instrumentation
    Software, AAS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software

    Technical notes
    | 2020 | Agilent Technologies
    Software, ICP/OES
    Instrumentation
    Software, ICP/OES
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma

    Technical notes
    | 2020 | Agilent Technologies
    Software, FTIR Spectroscopy
    Instrumentation
    Software, FTIR Spectroscopy
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Agilent ICP-MS Journal (July 2017 – Issue 69)

    Others
    | 2017 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Environmental, Pharma & Biopharma, Semiconductor Analysis

    Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

    Technical notes
    | 2021 | Agilent Technologies
    Software, ICP/MS
    Instrumentation
    Software, ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
     

    Related content

    ‌

    From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

    We, 29.5.2024
    Ústav organické chemie a biochemie AV ČR
    ‌

    Cryo-EM structures show how Trypanosomes escape the human innate immune response

    Tu, 28.5.2024
    Ústav organické chemie a biochemie AV ČR
    ‌

    An innovative approach to planar chiral substances

    Mo, 27.5.2024
    Katedra organické chemie Přírodovědecké fakulty Univerzity Karlovy
    ‌
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike